M, J., C, O., A, B., MA, C., T, G., P, P., . . . P, C. (2021). Early Post-Transplantation Serum Ferritin Level Predicts Survival in Recipients of Haploidentical Stem Cell Transplantation Using Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis. Transplantation and cellular therapy, 27(10), 861.e1-861.e7. https://doi.org/10.1016/j.jtct.2021.06.032
Chicago Style (17th ed.) CitationM, Jullien, et al. "Early Post-Transplantation Serum Ferritin Level Predicts Survival in Recipients of Haploidentical Stem Cell Transplantation Using Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis." Transplantation and Cellular Therapy 27, no. 10 (2021): 861.e1-861.e7. https://doi.org/10.1016/j.jtct.2021.06.032.
MLA (9th ed.) CitationM, Jullien, et al. "Early Post-Transplantation Serum Ferritin Level Predicts Survival in Recipients of Haploidentical Stem Cell Transplantation Using Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis." Transplantation and Cellular Therapy, vol. 27, no. 10, 2021, pp. 861.e1-861.e7, https://doi.org/10.1016/j.jtct.2021.06.032.